Abiopharma

🔍 Riley H Sanford (Director)

Company: CPI Card Group Inc. (PMTS)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Acquired 1,393 shares of Common Stock (Direct)
  Date: 2026-05-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 261,331.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-29 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 5,400.00 | Footnotes: F5
• Acquired 1,907 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,907.00 | transaction_form_type: 4 | Footnotes: F2, F1, F3, F3
• Sold 1,393 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-30 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F4

Footnotes:

• F1: Each restricted stock unit ("RSU") represents the right to receive one common share of the Issuer upon vesting of such RSU.
• F2: This line represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
• F3: The 1,907 RSUs reported on this line vest on the first anniversary of the May 29, 2026 award date, subject to the reporting person's continued service through such date or as otherwise provided for in the applicable award agreement.
• F4: This line reports 100% of the deferred RSUs that were awarded on the May 30, 2025 award date, which vested on the first anniversary of the award date.
• F5: The reporting person disclaims beneficial ownership of the securities held by the reporting person's spouse except to the extent of the reporting person's pecuniary interest therein.